Recruiting
Phase 1

COTI-2

Sponsor:

Critical Outcome Technologies Inc.

Code:

NCT02433626

Conditions

Ovarian Cancer

Fallopian Tube Cancer

Endometrial Cancer

Cervical Cancer

Peritoneal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

COTI2

Cisplatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Critical Outcome Technologies Inc. on 2019-02-01.